Who invested in Enterprise Therapeutics

4 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$80Mraised across 4 rounds since 2015, from 4 sources

$2.5MSeries A$3.7MSeries A$41MSeries B$33MSeries B

Latest round: Series B, $33MJan 2024
Biggest round: $41MSeries B · Apr 2018
Investors: 6

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20152017201920212023

$2.5MSeries A$3.7MSeries A$41MSeries B$33MSeries B

First round: Series A, $2.5M
Biggest round: $41M
Usual gap between rounds: 2.9 years

The rounds

Jan 2024
Series B$33M2 new2 returning
Source recorded
Apr 2018
Series B$41M2 new
- Versant Ventures
- Novartis
Reported by Fiercebiotech
May 2015
Series A$3.7M1 new1 returning
- Imperial Innovations Investment Management
- Epidarex Capital
From a historical funding record
Feb 2015
Series A$2.5M1 new
- Epidarex Capital
From a historical funding record

Founders and team

From Enterprise Therapeutics's own website: 11 on the team.

Dr John FordChief Executive Officer
Dr Phil BoydChief Financial Officer
Dr Renu GuptaChief Medical Officer
Prof Martin GoslingChief Scientific Officer
Annabella AmatulliHead of Regulatory
Dr Eddie FrenchHead of CMC
Dr Henry DanahayHead of Biology
Dr Sherry Armstrong-WilkinsonHead of Quality and Clinical
Dr Stephen CollingwoodHead of Chemistry
Joanne WagstaffHead of Finance
Kathy WoodwardClinical Project Manager

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2015Series A2015Series B2018Series B2024

Forbion Capital PartnersImperial Innovations Investment Management

Everyone who backed them

Versant VenturesVC firm2rounds

NovartisVC firm2rounds

Epidarex CapitalVC firm2rounds

IP GroupVC firm1round

Forbion Capital PartnersPrivate equity1round

Imperial Innovations Investment ManagementInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Enterprise Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Touchstone InnovationsVC firmPer its own site

Quick answers about Enterprise Therapeutics

Who invested in Enterprise Therapeutics?

Enterprise Therapeutics's investors include Versant Ventures, Novartis, Epidarex Capital, IP Group and Forbion Capital Partners, and 1 more on record.